Advertisement
U.S. markets open in 4 hours 27 minutes

Lexicon Pharmaceuticals, Inc. (LXRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.5200-0.0800 (-3.08%)
At close: 04:00PM EDT
2.5011 -0.02 (-0.75%)
After hours: 07:19PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/19/2024
Current
9/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
620.52M266.97M560.88M460.64M360.47M
Enterprise Value
508.09M115.77M510.53M377.57M254.89M
Trailing P/E
3.74N/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
984.60507.543.19k2.90k2.38k
Price/Book (mrq)
4.451.436.373.932.50
Enterprise Value/Revenue
958.66714.651.61k15.73k9.10k
Enterprise Value/EBITDA
-3.42-2.49-11.93-12.59-8.70

Trading Information

Stock Price History

Beta (5Y Monthly) 1.28
52-Week Change 310.04%
S&P500 52-Week Change 328.64%
52 Week High 33.7900
52 Week Low 30.9200
50-Day Moving Average 32.1610
200-Day Moving Average 31.7542

Share Statistics

Avg Vol (3 month) 34.73M
Avg Vol (10 day) 36.47M
Shares Outstanding 5246.24M
Implied Shares Outstanding 6246.24M
Float 899.5M
% Held by Insiders 11.65%
% Held by Institutions 177.58%
Shares Short (Feb 29, 2024) 421.07M
Short Ratio (Feb 29, 2024) 43.71
Short % of Float (Feb 29, 2024) 414.34%
Short % of Shares Outstanding (Feb 29, 2024) 48.63%
Shares Short (prior month Jan 31, 2024) 423.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3May 21, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-6,657.69%

Management Effectiveness

Return on Assets (ttm)-50.67%
Return on Equity (ttm)-165.87%

Income Statement

Revenue (ttm)1.2M
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)2,407.10%
Gross Profit (ttm)N/A
EBITDA -171.21M
Net Income Avi to Common (ttm)-175.61M
Diluted EPS (ttm)-0.7700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)170.03M
Total Cash Per Share (mrq)0.69
Total Debt (mrq)99.51M
Total Debt/Equity (mrq)105.16%
Current Ratio (mrq)N/A
Book Value Per Share (mrq)0.39

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A